Argenx Se (ARGX) Receivables - Net (2015 - 2025)

Argenx Se (ARGX) posted Receivables - Net of $1.6 billion for Q4 2025, down 99.86% on a QoQ basis from $1197.1 billion in Q2 2025, and up 82.06% year-over-year from $904.5 million in Q4 2024.

Argenx Se (ARGX) Receivables - Net (2015 - 2025) Analysis & Trends

Argenx Se's Receivables - Net history runs 11 years deep, the most recent figure standing at $1.6 billion for Q4 2025.

  • Quarterly Receivables - Net rose 82.06% year-over-year to $1.6 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 billion (up 82.06% YoY) and the FY2025 annual result came in at $1.6 billion, up 82.06% from the prior year.
  • Receivables - Net was $1.6 billion for Q4 2025 at Argenx Se, down from $1197.1 billion in the prior quarter.
  • Across five years, Receivables - Net topped out at $1197.1 billion in Q2 2025 and bottomed at $12.1 million in Q2 2021.
  • A 5-year average of $120.2 billion and a median of $425.0 million in 2023 frame the typical range for Receivables - Net.
  • Annual changes were most pronounced in 2021 — Receivables - Net grew 27.8% — and 2025, when it soared 183253.63%.
  • Argenx Se's Receivables - Net stood at $38.2 million in 2021, then surged by 621.32% to $275.7 million in 2022, then surged by 80.16% to $496.7 million in 2023, then surged by 82.1% to $904.5 million in 2024, then jumped by 82.06% to $1.6 billion in 2025.
  • Business Quant data shows ARGX's Receivables - Net at $1.6 billion in Q4 2025, $1197.1 billion in Q2 2025, and $904.5 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 1.65 Bn
Dec 31, 2025 1.65 Bn
Jun 30, 2025 1,197.07 Bn
Jun 30, 2025 1,197.07 Bn
Dec 31, 2024 904.47 Mn
Dec 31, 2024 904.47 Mn
Jun 30, 2024 652.88 Mn
Jun 30, 2024 652.88 Mn
Dec 31, 2023 496.69 Mn
Dec 31, 2023 496.69 Mn
Jun 30, 2023 353.23 Mn
Jun 30, 2023 353.23 Mn
Dec 31, 2022 275.70 Mn
Dec 31, 2022 275.70 Mn
Jun 30, 2022 112.39 Mn
Jun 30, 2022 112.39 Mn
Dec 31, 2021 38.22 Mn
Dec 31, 2021 38.22 Mn
Jun 30, 2021 12.05 Mn
Jun 30, 2021 12.05 Mn